organization · Reporting owner
EW HEALTHCARE PARTNERS FUND 2-A, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TELA Bio, Inc.TELA · Entity 7381 | 10% owner · See Remarks | November 17, 2025 | November 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TELA Bio, Inc.
Report date November 17, 2025 · Filed November 17, 2025
Jointly reported with EW HEALTHCARE PARTNERS FUND 2, L.P., EW Healthcare Partners Fund 2 GP, L.P., EW Healthcare Partners Fund 2-UGP, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 7,714,709 |
Reported balance
After 2025-11-17 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-11-17 · Purchase · Acquired 3,604,000 · Balance 7,714,709 F1: Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of the Issuer's common stock acquired in the Issuer's underwritten registered direct offering at a price of $1.11 per share. Consists of 1,416,249 shares acquired by EW Healthcare Partners Fund 2, L.P. and 2,187,751 shares acquired by EW Healthcare Partners Fund 2-A, L.P.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2021 Filed May 13, 2021 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $13.79 | $137,900.00 |
DisclosureSEC source: 0000899243-21-019414 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See Footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,534,578 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| February 04, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 2,822 | $14.29 | $40,326.38 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 10 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,524,578 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| February 02, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 250 | $14.08 | $3,520.00 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 9 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,521,756 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| February 01, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 1,119 | $14.16 | $15,845.04 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 8 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,521,506 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| January 29, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,760 | $13.93 | $108,096.80 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 7 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,520,387 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| January 28, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 13,950 | $13.68 | $190,836.00 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 6 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,512,627 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| January 27, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,000 | $14.03 | $70,150.00 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 5 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,498,677 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| January 26, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 1,544 | $14.24 | $21,986.56 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 4 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,493,677 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| January 15, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 763 | $13.88 | $10,590.44 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 3 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,492,133 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| January 14, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 9,075 | $13.96 | $126,687.00 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,491,370 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| January 13, 2021 Filed Feb 23, 2021 12:47 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,002 | $13.90 | $97,327.80 |
DisclosureSEC source: 0000899243-21-007752 · doc4.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · See footnote 2 EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · See footnote 2 EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner EW Healthcare Partners Fund 2-UGP, L.P. · CIK 0001793948 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 1,482,295 F1 · ownership.nature: Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase: F2 · ownership.nature: EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein. Read SEC document |
| August 28, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 100 | $12.85 | $1,285.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 26 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,475,293 F42 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 41 shares of the amount shown above and EW Fund 2-A purchased 59 shares of the amount shown above. Read SEC document |
| August 14, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 9,179 | $12.95 | $118,868.05 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 25 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,475,193 F41 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,732 shares of the amount shown above and EW Fund 2-A purchased 5,447 shares of the amount shown above. Read SEC document |
| August 11, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 821 | $12.95 | $10,631.95 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 24 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,466,014 F40 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 334 shares of the amount shown above and EW Fund 2-A purchased 487 shares of the amount shown above. Read SEC document |
| August 04, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,200 | $12.72 | $129,744.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 23 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,465,193 F39 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,148 shares of the amount shown above and EW Fund 2-A purchased 6,052 shares of the amount shown above. Read SEC document |
| August 03, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 1,400 | $11.86 | $16,604.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 22 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,454,993 F38 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 569 shares of the amount shown above and EW Fund 2-A purchased 831 shares of the amount shown above. Read SEC document |
| July 31, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 31,825 | $11.86 | $377,444.50 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 21 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,453,593 F36 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $12.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F37 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 12,941 shares of the amount shown above and EW Fund 2-A purchased 18,884 shares of the amount shown above. Read SEC document |
| July 30, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,400 | $12.22 | $90,428.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 20 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,421,768 F35 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,009 shares of the amount shown above and EW Fund 2-A purchased 4,391 shares of the amount shown above. Read SEC document |
| July 29, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 12,600 | $12.39 | $156,114.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 19 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,414,368 F33 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.34 to $12.40 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F34 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,124 shares of the amount shown above and EW Fund 2-A purchased 7,476 shares of the amount shown above. Read SEC document |
| July 28, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $12.48 | $124,800.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 18 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,401,768 F32 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above. Read SEC document |
| April 28, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 5,000 | $9.48 | $47,400.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 17 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,391,768 F31 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,033 shares of the amount shown above and EW Fund 2-A purchased 2,967 shares of the amount shown above. Read SEC document |
| April 23, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 15,000 | $9.98 | $149,700.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 16 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,386,768 F29 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F30 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. Read SEC document |
| April 22, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $9.14 | $91,400.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 15 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,371,768 F27 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $9.19 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F28 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above. Read SEC document |
| April 21, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 3,037 | $8.32 | $25,267.84 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 14 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,361,768 F26 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,235 shares of the amount shown above and EW Fund 2-A purchased 1,802 shares of the amount shown above. Read SEC document |
| April 20, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 7,000 | $8.06 | $56,420.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 13 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,358,731 F24 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.14 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F25 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,846 shares of the amount shown above and EW Fund 2-A purchased 4,154 shares of the amount shown above. Read SEC document |
| April 17, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 25,000 | $8.25 | $206,250.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 12 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,351,731 F22 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.18 to $8.29 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F23 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above. Read SEC document |
| April 16, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 17,500 | $8.00 | $140,000.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 11 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,326,731 F20 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F21 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,116 shares of the amount shown above and EW Fund 2-A purchased 10,384 shares of the amount shown above. Read SEC document |
| April 15, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 12,500 | $7.99 | $99,875.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 10 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,309,231 F18 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.97 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F19 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,083 shares of the amount shown above and EW Fund 2-A purchased 7,417 shares of the amount shown above. Read SEC document |
| April 14, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 15,000 | $8.07 | $121,050.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 9 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,296,731 F16 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.09 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F17 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. Read SEC document |
| April 13, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 10,000 | $7.96 | $79,600.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 8 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,281,731 F14 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.93 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F15 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above. Read SEC document |
| April 09, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 25,000 | $8.47 | $211,750.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 7 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,271,731 F12 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.35 to $8.58 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F13 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above. Read SEC document |
| April 08, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 15,000 | $8.37 | $125,550.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 6 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,246,731 F10 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.36 to $8.38 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. Read SEC document |
| April 07, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 20,000 | $8.20 | $164,000.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 5 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,231,731 F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.98 to $8.39 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 8,133 shares of the amount shown above and EW Fund 2-A purchased 11,867 shares of the amount shown above. Read SEC document |
| April 06, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 17,866 | $8.10 | $144,714.60 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 4 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,211,731 F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.16 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,265 shares of the amount shown above and EW Fund 2-A purchased 10,601 shares of the amount shown above. Read SEC document |
| April 03, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 9,634 | $8.01 | $77,168.34 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 3 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,193,865 F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,917 shares of the amount shown above and EW Fund 2-A purchased 5,717 shares of the amount shown above. Read SEC document |
| April 02, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 15,000 | $8.01 | $120,150.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 2 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,184,231 F3 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. Read SEC document |
| April 01, 2020 Filed Feb 16, 2024 16:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock, par value $0.001 per share | 15,000 | $7.47 | $112,050.00 |
DisclosureSEC source: 0000950170-24-016357 · ownership.xml · nonDerivative · entry 1 EW HEALTHCARE PARTNERS FUND 2, L.P. · CIK 0001746777 · 10% owner · See Remarks EW HEALTHCARE PARTNERS FUND 2-A, L.P. · CIK 0001746779 · 10% owner · See Remarks EW Healthcare Partners Fund 2 GP, L.P. · CIK 0001793943 · 10% owner · See Remarks EW Healthcare Partners Fund 2-UGP, LLC · CIK 0001793948 · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Remarks Disclosed balance after: 1,169,231 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.56 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: The share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("EW Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A," and together with EW Fund 2, the "EW Funds"), on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.